+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

R

Actively Recruiting

Researchers are evaluating the potential benefits and risks of active sub-threshold wireless neuromodulation stimulation for treating chronic knee pain caused by osteoarthritis. This trial aims to compare active stimulation versus no stimulation sham in reducing pain, with the primary goal of measuring the number of participants who experience at least a 50% decrease in pain on a visual analog scale after one month. Participants first undergo a diagnostic injection to confirm temporary pain relief before receiving a 7-day trial implant of the stimulation device near the target nerve. Those reporting more than 50% pain relief during this test proceed to receive a permanent implant under sedation. After a healing period of 10 days, participants are randomized to receive either active sub-threshold stimulation or sham stimulation for 30 days while both participants and staff remain unaware of group assignments. Stimulation programs include various high-frequency options. Throughout the study, participants attend in-person visits at 1 week, 1 month, 3 months, and 6 months post-randomization for physical exams, pain scales, knee function assessments, range of motion, work status, and medication use. Additional phone follow-ups are conducted at 12, 18, and 24 months to assess long-term pain relief and any adverse events. The study collects multiple outcome measures to evaluate the treatments impact on pain and physical function over time.

Age: 18Years +All GendersPhase Not Applicable
13 locations
E

Actively Recruiting

Researchers are evaluating the safety and effectiveness of the ReGelTec HYDRAFIL System in adults with axial chronic low back pain caused by degenerative disc disease DDD. This pivotal, multi-center, randomized controlled trial focuses on patients who continue to experience severe back pain and dysfunction after at least six months of conservative care. The study includes participants aged 22 to 85 years with symptomatic lumbar discs confirmed by imaging and discography. Participants are assigned to one of two groups the treatment arm receives the ReGelTec HYDRAFIL System hydrogel spinal implant combined with continued non-surgical conservative care, while the control arm receives conservative care plus a sham procedure involving needle advancement without muscle contact. After 24 months, eligible control participants may crossover to receive the treatment. The study monitors outcomes over at least 12 months and includes follow-up assessments. During the trial, participants undergo various evaluations including imaging MRI, discography, clinical assessments, and symptom monitoring. Researchers measure clinical success through a composite endpoint at 12 months. Participants are expected to adhere to follow-up schedules and complete questionnaires. Safety and effectiveness are continuously assessed throughout the study period, which extends up to the study completion date in late 2028.

Age: 22Years - 85YearsAll GendersPhase Not Applicable
16 locations
R

Actively Recruiting

Researchers are collecting real-world data on the use of the commercially approved Intracept10 Intraosseous Nerve Ablation Systems to treat patients diagnosed with vertebrogenic pain, including those with chronic low-back pain and vertebrogenic pain syndrome. The study aims to better understand outcomes from this minimally invasive procedure in routine clinical settings. Participants will receive treatment with the Intracept10 Intraosseous Nerve Ablation device following local instructions for use. The study observes patients who undergo this nerve ablation therapy without assigning participants to different groups, as it is an observational study without randomization or placebo. Throughout the study, participants will be monitored over 60 months after the procedure. Researchers will assess changes in disability using the Oswestry Disability Index ODI and gather other outcome data to evaluate the impact of treatment. Participation involves regular follow-up to document treatment effects and safety over time.

Age: 18Years +All Genders
22 locations
M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations